RXSIGHT INC (RXST)
US78349D1072 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to RXST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 64.26. This target is 90.91% above the current price.
RXST was analyzed by 15 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about RXST.
In the previous month the buy percentage consensus was at a similar level.
RXST was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | Stifel | Downgrade | Buy -> Hold |
| 2024-12-11 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-06 | UBS | Initiate | Buy |
| 2024-10-29 | Jefferies | Initiate | Buy |
| 2024-09-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-20 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-06 | Stifel | Maintains | Buy -> Buy |
| 2024-08-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-07-15 | BTIG | Maintains | Buy -> Buy |
| 2024-07-10 | Stifel | Maintains | Buy -> Buy |
| 2024-05-07 | BTIG | Maintains | Buy -> Buy |
| 2024-05-07 | Needham | Maintains | Buy -> Buy |
| 2024-05-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-06 | Stifel | Maintains | Buy -> Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-02-29 | Needham | Maintains | Buy -> Buy |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-29 | Stifel | Maintains | Buy -> Buy |
| 2024-02-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-12 | Stifel | Maintains | Buy -> Buy |
| 2024-01-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-08 | Needham | Maintains | Buy -> Buy |
| 2024-01-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-13 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023-12-12 | Stifel | Initiate | Buy |
| 2023-12-04 | Morgan Stanley | Initiate | Overweight |